首页> 外文期刊>Clinical ophthalmology >Assessment of corneal hysteresis measured by the ocular response analyzer as a screening tool in patients with glaucoma
【24h】

Assessment of corneal hysteresis measured by the ocular response analyzer as a screening tool in patients with glaucoma

机译:通过眼反应分析仪测量的角膜滞后评估作为青光眼患者的筛查工具

获取原文
           

摘要

Background: Corneal hysteresis (CH) is used to determine the level of risk of patients developing glaucoma, categorized as suspect, mild, moderate and severe. Methods: This is a retrospective review of 126 consecutive eyes presenting, for the first time, at a glaucoma subspecialty clinic. All eyes at initial examination underwent measurement of CH and intraocular pressure using the Goldmann applanation tonometry (IOPgat). Eyes were classified as CH10 (n=51) or CH≥10 (n=75) and categorized into glaucoma suspect, mild, moderate, or severe glaucoma based on 24-2 Humphrey visual field testing. Additional data included number of topical glaucoma medications. Results: Of the eyes classified as a CH10, 45.5% had moderate or severe glaucoma, and 11.8% of eyes with a CH≥10 had moderate or severe glaucoma. In the CH≥10 group, the mean IOPgat was 19.5 mmHg ± 4.72 mmHg ( P 0.01) on 1 ± 1.26 ( P 0.01) medications in the moderate/severe glaucoma group and 20.13 mmHg ± 4.95 mmHg ( P 0.01) on 0.60 ± 0.95 ( P 0.01) medications in the glaucoma suspect/mild glaucoma group. In the CH10 group, mean IOPgat was 20.47?mmHg ± 7.56 mmHg ( P 0.01) on 1.79 ± 1.17 ( P 0.01) medications in the moderate/severe glaucoma group. Mean IOPgat was 17.54 mmHg ± 5.48 mmHg ( P 0.01) on 0.63 ± 0.83 ( P 0.01) medications in the glaucoma suspect/mild glaucoma group. Conclusion: Moderate to severe glaucoma is 2.9 ( P 0.01) times more likely to occur in eyes that measure a CH10 compared to eyes that measure a CH≥10. Although not statistically significant, suspect or mild glaucoma is more common in eyes that measure a CH≥10. Eyes in the CH10 moderate/severe glaucoma group had statistically significant higher IOPgat ( P 0.01) compared to the CH10 suspect/mild glaucoma group. Measuring CH at initial presentation can help predict the severity of glaucoma.
机译:背景:角膜滞后(CH)用于确定青光眼患者的风险等级,分为可疑,轻度,中度和重度。方法:这是对青光眼亚专科诊所首次出现的126只连续眼睛的回顾性回顾。初次检查时,所有眼睛均使用Goldmann压平眼压计(IOPgat)测量CH和眼压。根据24-2汉弗莱视野测试,将眼睛分为CH <10(n = 51)或CH≥10(n = 75),并分为可疑青光眼,轻度,中度或重度青光眼。其他数据包括局部青光眼药物治疗的数量。结果:分类为CH <10的眼中,有45.5%患有中度或重度青光眼,而CH≥10的眼中有11.8%的眼具有中度或重度青光眼。在CH≥10组中,中度/重度青光眼组中1±1.26(P <0.01)药物的平均IOPgat为19.5 mmHg±4.72 mmHg(P <0.01),而在20±13组则为20.13 mmHg±4.95 mmHg(P <0.01)在可疑/轻度青光眼组中使用0.60±0.95(P <0.01)药物。在CH <10组中,中度/重度青光眼组的1.79±1.17(P <0.01)药物平均IOPgat为20.47?mmHg±7.56 mmHg(P <0.01)。青光眼可疑/轻度青光眼组药物的平均IOPgat为0.63±0.83(P <0.01)药物为17.54 mmHg±5.48 mmHg(P <0.01)。结论:与测量CH≥10的眼睛相比,测量CH <10的眼睛中度至重度青光眼的发生率高2.9倍(P <0.01)。尽管没有统计学意义,可疑或轻度青光眼在测量CH≥10的眼睛中更为常见。与CH <10疑似/轻度青光眼组相比,CH <10中等/重度青光眼组的眼具有较高的IOPgat(P <0.01),具有统计学意义。在初次就诊时测量CH可帮助预测青光眼的严重程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号